Skip to content
Screener

PROCEPT BioRobotics Corporation PRCT EPS (Diluted)

EPS (Diluted) at other companies

TFX
TeleflexTFX
$2.28-17.7%
Boston Scientific logo
Boston ScientificBSX
$0.61+15.1%
Intuitive Surgical logo
Intuitive SurgicalISRG
$2.29+26.5%
PDE
Pro-Dex, Inc.PDEX
$1.20+22.4%
Microbot Medical logo
Microbot MedicalMBOT
-$0.05+37.5%
iRadimed logo
iRadimedIRMD
$0.45+21.6%

Other financials

Income statement

See full
Revenue$94.5M+19.3%
Gross profit$62.4M+20.5%
Operating income-$27.4M-23.4%
Net income-$26.9M-37.2%

Balance sheet

See full
Cash & equivalents$11.4M-96.3%
Total debt$77.5M-2.4%
Total equity$340.1M-11.9%
Total assets$479.4M-6.6%

Cash flow

See full
Operating cash flow-$19.3M-28.0%
CapEx$3.0M+5.4%
Free cash flow-$22.2M-24.4%

Valuation

See full
Market cap$1.15B-25.9%
Enterprise value$1.21B—
P/S3.4×—

Profitability

See full
Gross margin64.2%0.0pp
Operating margin-33.9%+0.5pp
Net margin-32.5%+2.2pp
FCF margin-25.2%-4.6pp

Returns & leverage

See full
Return on equity-30.2%+5.2pp
Debt / equity0.2×0.0×
Current ratio6.5×-2.7×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: PROCEPT BioRobotics Corporation’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001588978-26-000030
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Loss before provision for income taxes(26,767)(19,442)(58,448)(44,227)
Provision for income taxes941365189
Net loss$(26,861)$(19,578)$(58,499)$(44,316)
Net loss per share, basic and diluted$(0.47)$(0.35)$(1.03)$(0.80)
Weighted-average common shares used to
compute net loss per share attributable to
common shareholders, basic and diluted57,06755,44556,79055,182
Other comprehensive loss:

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is PROCEPT BioRobotics Corporation's EPS (diluted)?
PROCEPT BioRobotics Corporation (PRCT) reported EPS (diluted) of -$0.47 in Q2 2026.
How has PROCEPT BioRobotics Corporation's EPS (diluted) changed year-over-year?
PROCEPT BioRobotics Corporation's EPS (diluted) decreased by 34.3% year-over-year, from -$0.35 to -$0.47.
What is the long-term trend for PROCEPT BioRobotics Corporation's EPS (diluted)?
Over 3 years (2022 to 2025), PROCEPT BioRobotics Corporation's EPS (diluted) has grown at a -4.4% compound annual growth rate (CAGR), from -$1.96 to -$1.71.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about PROCEPT BioRobotics Corporation's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude